PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.07%
Growth of 1.07% while AVGO shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
8.86%
Cost growth of 8.86% while AVGO maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
-6.06%
Gross profit decline while AVGO shows 0.00% growth. Joel Greenblatt would examine competitive position.
-7.06%
Margin decline while AVGO shows 0.00% expansion. Joel Greenblatt would examine competitive position.
3.89%
R&D change of 3.89% while AVGO maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.07%
Operating expenses reduction while AVGO shows 0.00% growth. Joel Greenblatt would examine advantage.
4.88%
Total costs change of 4.88% while AVGO maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
1.96%
D&A change of 1.96% while AVGO maintains D&A. Bruce Berkowitz would investigate efficiency.
-7.54%
EBITDA decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-8.52%
EBITDA margin decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-10.44%
Operating income decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-11.40%
Operating margin decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-41.18%
Other expenses reduction while AVGO shows 0.00% growth. Joel Greenblatt would examine advantage.
-11.06%
Pre-tax income decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-12.00%
Pre-tax margin decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-26.34%
Tax expense reduction while AVGO shows 0.00% growth. Joel Greenblatt would examine advantage.
-4.25%
Net income decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-5.27%
Net margin decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-4.44%
EPS decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-2.27%
Diluted EPS decline while AVGO shows 0.00% growth. Joel Greenblatt would examine position.
-1.21%
Share count reduction while AVGO shows 0.00% change. Joel Greenblatt would examine strategy.
-1.72%
Diluted share reduction while AVGO shows 0.00% change. Joel Greenblatt would examine strategy.